Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-07

Clinical Trial Update: Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant [Phase 3]

View source ↗

Summary

Phase 3 study of belatacept in renal transplantation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Belatacept (Nulojix) (belatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Renal Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2017-07-07